Why the study?
Does a novel null homozygous mutation in CACNA2D2 contribute to epileptic encephalopathy?
Population
A single patient with epilepsy, dyskinesia, cerebellar atrophy, psychomotor delay and dysmorphic features…
Design
Case_report
Authors
Loading...
May warrant CACNA2D2 screening in unexplained epileptic encephalopathy; leaves open confirmatory studies.
Does a novel null homozygous mutation in CACNA2D2 contribute to epileptic encephalopathy?
The identification of a novel null homozygous mutation in CACNA2D2 confirms its causal role in epileptic encephalopathy.
Pippucci et al. (2013) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: